Health and Fitness Health and Fitness
Thu, February 16, 2012
[ Thu, Feb 16th 2012 ] - Market Wire
HeartWare International Reports Fourth Quarter 20 .. #59; Full Year 2011 Revenues of $82.8 Million
[ Thu, Feb 16th 2012 ] - Market Wire
ICON reports fourth quarter 2011 revenue of $243m .. of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (
[ Thu, Feb 16th 2012 ] - Market Wire
Acorda Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results
[ Thu, Feb 16th 2012 ] - Market Wire
Astex Pharmaceuticals to Host Annual Analyst and Investor Day on March 27, 2012
[ Thu, Feb 16th 2012 ] - Market Wire
Spectranetics Fourth Quarter Revenue Increases 11% to $32.5 Million
[ Thu, Feb 16th 2012 ] - Market Wire
BioCryst Reports Fourth Quarter and Full Year 2011 Financial Results
Wed, February 15, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Alnylam Pharmaceuticals Announces Exercise of Ove .. lotment Option in Public Offering of Common Stock
[ Wed, Feb 15th 2012 ] - Market Wire
NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance
[ Wed, Feb 15th 2012 ] - Market Wire
Wright Medical Group, Inc. to Participate in the 2012 RBC Capital Marketsa Healthcare Conference
[ Wed, Feb 15th 2012 ] - Market Wire
Insulet Announces Global Agreement With LifeScan, .. uch Blood Glucose Monitoring Technologies Into th
[ Wed, Feb 15th 2012 ] - Market Wire
Halozyme Announces Exercise in Full of Over-Allot .. Option and Completion of Public Offering of Stock
[ Wed, Feb 15th 2012 ] - Market Wire
Uroplasty Announces Enrollment of First Patients .. dy for Treatment of Fecal Incontinence with Urgen
[ Wed, Feb 15th 2012 ] - Market Wire
Delcath CHEMOSAT Presented as Innovative Treatmen .. iver Metastases by European Institute of Oncology
[ Wed, Feb 15th 2012 ] - Market Wire
OPKO Health, Inc. Invests in ChromaDex Corp.
[ Wed, Feb 15th 2012 ] - Market Wire
ERT Launches New Website to Support Significant Commercial Growth
[ Wed, Feb 15th 2012 ] - Market Wire
ERT to Report Fourth Quarter and Full Year 2011 Operating Results
[ Wed, Feb 15th 2012 ] - Market Wire
IsZo Capital Writes to Special Committee of Taro .. ing the Immediate Rejection of Sun's Buyout Offer
[ Wed, Feb 15th 2012 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of SeraCare Life Sciences, Inc.
[ Wed, Feb 15th 2012 ] - Market Wire
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gela"
[ Wed, Feb 15th 2012 ] - Market Wire
ViroPharma to Release 2011 Fourth Quarter and Full Year Financial Results on February 28, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Derma Sciences to Present at the LHA Life Sciences & Medtech Virtual Conference on February 16
[ Wed, Feb 15th 2012 ] - Market Wire
Accuray Incorporated to Speak at Citi 2012 Global Health Care Conference
[ Wed, Feb 15th 2012 ] - Market Wire
Aeolus Announces No-Cost Extension and Modificati .. lued at $118 Million to Develop Treatment for Lun
[ Wed, Feb 15th 2012 ] - Market Wire
Leisureworld Announces February Dividend
[ Wed, Feb 15th 2012 ] - Market Wire
China Sky One Medical Reiterates CEO Sick Leave a .. ounces Significant Middle Management Resignations
[ Wed, Feb 15th 2012 ] - Market Wire
Verisante Technology, Inc. Named Top Technology a .. es Company on the TSX Venture Top 50 2012 Ranking
[ Wed, Feb 15th 2012 ] - Market Wire
UnitedHealth Group Inc., Lowe's Companies, Inc., .. rtners L.P., Cosan Ltd. and Landstar System, Inc.
[ Wed, Feb 15th 2012 ] - Market Wire
Amgen and Micromet Announce Early Termination of .. aiting Period for Amgen's Acquisition of Micromet
[ Wed, Feb 15th 2012 ] - Market Wire
Merck forma joint venture com Supera Farma para a .. rmacuticos inovadores e genricos de marca no Bras
[ Wed, Feb 15th 2012 ] - Market Wire
Baxter to Present at the Citi 2012 Global Healthcare Conference

Baxter to Present at the Citi 2012 Global Healthcare Conference


Published on 2012-02-15 06:21:05 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Citi 2012 Global Healthcare Conference on Wednesday, February 29, 2012, at 10:00 a.m. (ET).

The live webcast of Baxteras presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through March 29, 2012.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources